" class="no-js "lang="en-US"> Appointments Archives - Medtech Alert
Sunday, March 26, 2023

Sort by:


Top Post

Almirall Appoints Mercedes Diz as VP, Corporate Strategy

Almirall, a global biopharmaceutical company focused on skin health, today announced that Mercedes Diz will […]

Celyad Oncology Appoints Georges Rawadi as Its New CEO

Celyad Oncology, a biotechnology company focused on innovative technologies for chimeric antigen receptor (CAR) T-cell […]

Vividion Therapeutics Promotes Matt Patricelli to Chief Scientific Officer

Vividion Therapeutics, a biopharmaceutical company utilizing novel discovery technologies to unlock high-value, traditionally undruggable targets […]

Morphimmune Appoints Dr. Clay Siegall Chief Executive Officer and President

Morphimmune, a preclinical biotechnology company focused on developing targeted oncology therapeutics, today announced the appointment […]

Capstan Therapeutics Appoints Justin Thacker as Chief Financial Officer and Jeffrey Pepe, J.D., Ph.D., as General Counsel

Capstan Therapeutics, a biotechnology company dedicated to advancing in vivo reprogramming of cells through targeted […]

Ankyra Therapeutics Appoints Experienced Financial Executive Stephen Gorgol as Chief Financial Officer

Ankyra Therapeutics, a biotech company developing targeted immune-activating agents for the treatment of cancer, has […]

Semler Scientific Names Wayne T. Pan, M.D., Ph.D., M.B.A. as New CEO

Semler Scientific, a company that provides technology solutions to improve the clinical effectiveness and efficiency […]

Axel Hoos, MD, PhD, Joins NextPoint Therapeutics Board of Directors

NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that […]

Gamida Cell Announces Changes to Board of Directors

Gamida Cell, a cell therapy pioneer working to turn cells into powerful therapeutics, today announced […]

Ascidian Therapeutics Appoints Jay A. Barth, M.D., as Chief Medical Officer

Ascidian Therapeutics, a biotechnology company focused on treating human diseases by rewriting RNA, announced today […]

Nanoscope Therapeutics Appoints Industry Veteran Vicente Anido Jr., Ph.D., as a Strategic Advisor

Nanoscope Therapeutics, a clinical-stage biotechnology company developing gene therapies for retinal degenerative diseases, today announced […]

  1. Illumina and GenoScreen Launch Next Generation Sequencing Innovation to Eliminate Tuberculosis in Africa Read more
  2. Celyad Oncology Appoints Georges Rawadi as Its New CEO Read more
  3. Companion Spine Closes $60.1 Million Series A Funding Round Read more
  4. EVERSANA® Announces Partnership with ChemoMouthpiece, LLC to Support U.S. Launch & Commercialization of Medical Device to Help Cancer Patients Manage and Treat Oral Mucositis Read more
  5. Vividion Therapeutics Promotes Matt Patricelli to Chief Scientific Officer Read more